Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

February
14
2020

Non-Melanoma Skin Cancer Patient Testimonials

Hear from the patients themselves! These individuals had their non-melanoma skin cancer treated with SRT and have achieved amazing results.

February
13
2020

Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

February
06
2020

Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020

BOCA RATON, Fla. , Feb. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a…

January
30
2020

What are the Causes of Keloids?

Keloids are a type of scar composed of collagen. They can be firm or rubbery with a shiny, brown or pink appearance. Although sometimes painful or itchy, they usually pose no threat to your overall…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy